Cochrane Abstracts
Heparin versus normal saline for patency of arterial lines
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Heparin Versus Normal Saline for Patency of Arterial Lines." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431338/all/Heparin_versus_normal_saline_for_patency_of_arterial_lines.
Heparin versus normal saline for patency of arterial lines. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431338/all/Heparin_versus_normal_saline_for_patency_of_arterial_lines. Accessed January 16, 2025.
Heparin versus normal saline for patency of arterial lines. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431338/all/Heparin_versus_normal_saline_for_patency_of_arterial_lines
Heparin Versus Normal Saline for Patency of Arterial Lines [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431338/all/Heparin_versus_normal_saline_for_patency_of_arterial_lines.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Heparin versus normal saline for patency of arterial lines
ID - 431338
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431338/all/Heparin_versus_normal_saline_for_patency_of_arterial_lines
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
